Subjects will be administered multiple doses of VK0214 in a cohort dose escalation process. A total of up to 36 subjects will be enrolled in the study, into one of three dose cohorts. For each cohort, up to 12 subjects will be randomized to receive…
- Investigator
- S Parrish Winesett
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All